Introduction
The lung arises as an out-pocketing from the primitive esophagus at embryonic day 9 (E9) in the mouse. Thereafter, the organ develops as a repeatedly branching system of tubules composed of endodermally derived epithelium surrounded by mesenchyme of mesodermal origin. The epithelial compartment ultimately gives rise to the majority of the cell types that are specifically related to the specialized function of the lung. These specialized cell types include the Type I and Type I1 alveolar cells that comprise the respiratory epithelium lining the most distal segments of the ma- terns were recapitulated in serumless organ culture, demonstrating that information necessary to generate both phases of gene expression is present within the lung anlage by Ell. We conclude that CGRP, CClO, and SPA are m-expressed in most or all cells of the distal lung epithelium at E13415 and later become restricted to different cell lineages. This transient expression in progenitor cells of gene products characteristic of diverse differentiated cell types may reflect an underlying mechanism of gene regulation. ( J Histochem renewal of the epithelium (6, 8) and during normal development (29). The lineage relationship between the two putative stem cells (Type I1 cell and Clara cell) is not known, nor is it known what determines the differentiation of different epithelial cell types at different airway levels. In addition, lineage studies have not addressed the relationship of PNE cells to the other epithelial cell types. PNE cells possess a neuroendocrine phenotype, yet they apparently derive from the lung epithelium (11,12) rather than from the neural crest, as was once believed ( 5 ) . Although Clara cells appear to be the progenitors of the other bronchiolar epithelial cell types, PNE cells differentiate morphologically before any other epithelial cell type, including Clara cells, in rodents and humans (12, 15, 25) .
One way to approach the study of differentiation of cell lineages is to examine the developmental patterns of expression of selected marker gene products that are representative of different mature cell types. Marker proteins that can be used in this way to study differentiation of lung epithelial cells include calcitonin generelated peptide (CGRP), Claracell lo-KD protein (CClo), and surfactant protein-A (SP-A). CGRP is restricted to nerve fibers and PNE cells in the lungs of various species (4, 17) . This neuropeptide is one of several peptide hormones localized in PNE cells by immunohistochemistry (23, 37, 39) , and localization of CGRP mRNA in PNE cells by in situ hybridization has demonstrated that CGRP is indeed synthesized in these cells (17) . In our hands, CGRP has proven to be the most reliable and sensitive immunohistochemical marker for PNE cells in the mouse (M.E. Sunday, unpublished observation). CC10 is an abundant secretory Clara cell protein of uncertain function (26, 32, 33) . CClO has been reported to be a specific immunohistochemical marker for Clara cells in the lungs of rat, mouse, and hamster (3, 34, 43) , and its synthesis in Clara cells has been confirmed by in situ hybridization (9, 38) . Although CClO mRNA is detected in Type 11 cells in rat by in situ hybridization (38), we have not observed CC10-like immunoreactivity in adult Type I1 cells of rat, mouse, or hamster (3.34) or in differentiating mouse Type I1 cells as late as 18 days' gestation (E18), suggesting that the message may be transcribed but not translated in Type I1 cells. SP-A is one of the major constituent proteins of pulmonary surfactant, the complex of lipids and proteins secreted by Type I1 cells of the alveolar epithelium that functions to prevent collapse of the alveoli during respiration (46). It is clear that SP-A is synthesized by Type I1 alveolar cells, based on in situ localization of SP-A mRNA (2, 28) , and on immunohistochemical subcellular localization of SP-A protein (43, 44) . SP-A andlor its mRNA have also been reported in mature Claracells in rabbit, rat, and human (2, 18, 27) . It therefore appears that there is phenotypic overlap between mature Clara cells and Type I1 cells, at least with respect to expression of SP-A and possibly of CC10. This overlap of phenotype could reflect coordinate expression of the respective genes and a possible close lineage relationship between Clara cells and Type I1 cells. Alternatively, phenotypic overlap could represent convergence of function between two cell types that are otherwise not very closely related.
The work reported here grew out of a study of PNE cells in developing fetal mouse lung in vivo and in serumless organ culture. In these experiments, an antibody directed against rat CGRP yielded a pattern of generalized immunostaining throughout the epithelium in the smaller, more peripheral airways at E13, E14, and E15 before the first appearance of stained PNE cell clusters (neuroepithelial bodies; NEBS) at E16. This unanticipated result suggested that an entire epithelial stem cell population expresses a gene product that is ultimately restricted to a single differentiated cell type. We wondered whether this pattern of expression might be specific to CGRP or to PNE cell-specific gene products, or whether it might be more general. This, in turn, led us to investigate patterns of expression of marker proteins for other differentiated epithelial cell types (CC10 and SP-A). We have also examined expression of the same set of marker proteins in serumless organ culture to determine whether the developmental patterns observed in vivo are recapitulated in this culture system. Earlier studies utilizing this culture system have demonstrated cytodifferentiation of ciliated cells and Type I1 cells containing characteristic lamellar bodies and expressing SP-A without addition of growth factors or hormones (14, 35) .
This study reports the observation that antibodies directed against CGRP, COO, and SP-A yield virtually identical patterns of immunoreactivity in the developing airway epithelium of E13-El5 embryonic mouse lungs, implying co-expression by a progenitor cell population of gene products that are differentially expressed among three distinct mature epithelial cell types. Almost identical patterns of immunostaining for CGRP, CC10, and SP-A were also observed in the epithelium of embryonic mouse lungs dissected at E l l and cultured for 4 days in serumless chemically defined medium.
Materials and Methods
Animals. Timed-pregnant female Swiss-Webster mice were obtained from Simonsen (Gilroy, CA) and were housed and handled according to the practices established by the institutional animal use committee until sacrifice by cervical dislocation. Embryos or fetuses were removed, decapitated, and lungs dissected in sterile Hank's balanced salt solution.
Organ Culture. The serumless organ culture system has been described previously (14) . Briefly, lungs were dissected from embryos at 11 days' gestation (Ell) as above and were placed on Millipore Filters (type AA, 0.80 pm, black: Millipore, Bedford, MA) resting on stainless steel wire mesh. Lungs were cultured at the air-medium interface in chemically defined medium (Fitton-Jackson modified BGJb; Gibco. Grand Island, NY) containing 0.2 mglml ascorbic acid. Cultures were incubated under 5 % CO2 at 37°C for up to 12 days (E11+12).
Preparation of Tissue Sections. Dissected lung lobes for in vivo studies were fixed for 41 min to 3 hr, depending on size, at 4°C in 4% paraformaldehyde-phosphate-buffered saline (PBS; 10 mM phosphate, pH 7.2, 150 mM NaCI). Lungs explanted and grown in culture were fixed for 4-5 hr in the same manner. After fixation, tissues were dehydrated through graded ethanol solutions and embedded in paraffin. Sections were cut at 5 pm or 4 pm thickness and were mounted on slides coated with 3-aminopropyltriethoxysilane (TESPA) according to Wilkinson and Green (48) .
Antibodies. Polyclonal rabbit antiserum directed against rat calcitonin gene-related peptide (CGRP) was obtained from Peninsula Laboratories (Belmont, CA) and used at 1:3000-1:5000 dilution. Rabbit anti-rat CClO polyclonal antiserum was produced in the laboratory of Dr. Gurmukh Singh (31) 
Results

In Vivo Studies
We examined lung tissue from embryos of 13 days' gestation (E13) through 18 days' gestation (EN) (term is 19 days in the mouse). Tissue was prepared as described and sections were reacted with one of three specific polyclonal antisera directed against CGRP, CC10, or SP-A. After immunohistochemical detection, the developmental pattern of immunostaining for each of the three antibodies was analyzed by light microscopy. Our analysis revealed that the staining patterns of all three antisera show two distinct developmental phases, with the transition from the earlier phase to the later phase occurring at about E16, or approximately at the time of transition from the pseudoglandular to the canalicular.stage of lung development in the mouse (41).
Immunohistochemical Staining from E13-EIS
The patterns of immunostaining that characterize the earlier phase of development are shown in Figures 1A-IC in adjacent sections of E14 lung reacted with anti-CGRP, anti-CC10, and anti-SP-A. The striking feature of our results at this developmental stage was the remarkable similarity of the patterns obtained with all three antibodies ( Figures 1A-IC ). All three antisera produced staining in the epithelium of the smaller, more peripheral airways, whereas the epithelium of the larger proximal airways showed little or no staining. The staining in the small airway epithelium tended to be continuous, i.e., the staining was not interrupted by single cells or groups of cells that were unstained. The staining was often strongest at the luminal edge of the epithelium, although this may merely reflect the facts that the staining was cytoplasmic and that the nuclei appeared to be positioned towards the base of these cells.
Data for all three antibodies indicated that this pattern is already established at E13 and extends through E15 (data not shown). The epithelium of the larger airways in the sections was unstained at E13, whereas the epithelium of the smaller airways was stained by all three antibodies. The staining patterns obtained with the three antibodies in sections of E15 lung resembled the E14 patterns, but with some differences. The maximal level of staining at E15 was not as high as at E14. Staining was still confined to the epithelium of small airways, but the staining was often stronger in small airways nearer the periphery of the section than in those that were more centrally located.
The presence or absence of staining in the epithelium from E14 onwards correlated with the morphological appearance of the epithelium. The epithelium of the small distal airways, which was stained by all three antibodies, is a low cuboidal epithelium. The epithelium of the large proximal airways is taller, consisting of columnar cells, which were relatively unstained. Figure 1F illustrates this in an obliquely sectioned airway profile in a section of E14 lung reacted with anti-CC10 antiserum. The section intersects a region of the airway at which there is a transition from proximal (large arrow) to distal (small arrows) epithelium. (The edge of the lobe is just visible in the upper right-hand corner.) There is an apparent gradient of staining increasing towards the periphery, and the transition from tall columnar to low cuboidal epithelium parallels this gradient of immunostaining. We have observed the same morphological transition and gradient of immunostaining in longitudinally or obliquely sectioned airway profiles in sections reacted with anti-CGRP or with anti-SP-A (data not shown).
CGRE CClO, and SPA Antisera Stain Overlapping Populations at E13-ElS
We were not able to use a double staining method to demonstrate co-localization of staining in the same cell because all three antisera were produced in rabbits. Nevertheless, the three staining patterns were so nearly identical in adjacent sections of E14 lung that the populations of cells stained by the three antisera must be overlapping if not in fact identical. Because the three different antisera all gave the same staining pattern at E14, we were concerned about the specificity of the staining, particularly since all three antisera were raised in the same species. For CGRP and CC10. we were able to obtain enough purified antigen to do preabsorption controls. The results are shown in Figures 1D-1G . In both cases, staining was eliminated by preabsorption of the antiserum with the appropriate antigen ( Figures 1E and IG) .
Immunohistochemical Staining from E16 Through E18
The later phase was characterized by emergence of the differentiated cell type-specific staining patterns expected from previous studies of CGRP and CClO (34, 39) or from the literature in the case of SP-A (18,22,27). Large proximal airways were distinguished throughout this period by the morphology of their epithelium as well as by their size. The luminal aspect of these airways was characterized by many irregular ridges, giving a pleated appearance in transverse section. These structures correspond to midsized conducting airways. The cross-sectional profiles of the smaller airways became increasingly complex during this period, and the epithelium of these airways became less clearly distinguishable from the adjacent mesenchymal cells. The more proximal of these structures correspond to small conducting airways, and the more distal ones will ultimately become respiratory airways and mature alveoli.
E16 lungs appeared to be transitional between the earlier and later developmental phases, in that elements of both immunostaining patterns were often present in the same section. The nature and the timing of the transition in immunostaining patterns was different for the three different antibodies. These features are shown in Figure 2 , which shows at low magnification the distribution of immunostaining in three adjacent sections reacted with anti-CGRP, anti-CC10, or anti-SP-A. The selected fields contain three large airways cut transversely (arrowheads) grouped near a large blood vessel (v) located in the central area of the lobe, with one edge of the lobe visible at the top of the figure. In the anti-CGRP-stained section (Figure 2A ), a low level of staining in the epithelium of the small airways is still seen and is slightly stronger towards the periphery of the section. At the same time, stained foci representing clusters of PNE cells have begun to appear in the epithelium of the large airways (small arrows). In the anti-CC10-reacted section ( Figure 2B ), staining of small airway epithelium has almost completely disappeared except near the edge of the section, and staining has become apparent in the epithelium of all of the large airways (arrowheads). The transition is least advanced in the anti-SPA-stained section (Figure 2C) where it is evidenced only by the reduced staining of the epithelium of the small airways in the center of the section relative to the periphery and by an increased "spottiness" or discontinuity of the small airway staining (an almost granular quality at this magnification). Although the presumptive Clara cell population in the large airway epithelium has apparently already begun to stain for CClO ( Figure 2B ), this population does not yet show any staining for SP-A at E16 ( Figure 2C ).
The extent of the transition appeared to vary from one E16 lung to another in a manner that suggests variation in the exact developmental age of the specimen. The specimen shown in Figure 2 appears relatively immature compared to some E16 lungs that showed little or even no staining of small airway epithelium with either anti-CGRP or anti-CC10 antibodies. Sections from these lungs also showed larger numbers of more intensely stained foci in the epithelium of the larger airways when stained for CGRP and much more intense staining of the large airway epithelium when stained for CClO. Similarly, some E16 lungs showed less staining of small airways with anti-SP-A than the example shown in Figure 2 . Some age variation among the specimens is likely to exist because the exact time of mating of the pregnant mice used in this study probably varied by a few hours, as did the time of sacrifice.
The staining patterns observed at E17 for anti-CGRP and antiCClO were very similar to those just described for the apparently more mature specimens of E16 lung tissue (data not shown). It therefore appears that the transition between the earlier and later stages is complete by E17 for these two marker proteins, although additional changes not documented in this study may have occurred in the number of anti-CGRP-positive foci or the extent of the regions of CC10 immunostaining. In contrast, the pattern of immunostaining observed with anti-SP-A antisera changed from E16 to E17 and further changes occurred between E17 and E18. Anti-SP-A immunostaining in the epithelium of the distal small airways did not fade away and disappear in the same manner as did the small airway staining seen with anti-CGRP and anti-CC10 antibodies. Instead, anti-SP-A staining became increasingly discontinuous as increasing numbers of epithelial cells apparently ceased to express the protein. At E17 the epithelium of the large proximal airways still remained unstained by the anti-SP-A antibody.
CGRe CClO, and SPA Antisera Yield Distinct Staining Patterns at E18
By E18, the three antibodies gave distinctly different staining patterns (Figures 3 and 4 ) . Although there was overlap in the staining patterns seen with anti-CC10 and anti-SP-A in epithelial cells of the large airways and proximal small airways (in the presumptive Clara cells), the staining patterns of these two antibodies were clearly distinct in a number of ways, and there appeared to be no overlap between either of these patterns and that obtained with anti-CGRP (see especially Figures 4A-4C) .
Anti-CGRP immunostaining at E18 was restricted to scattered foci occurring most frequently in the epithelium of large proximal airways and more rarely in small airways, but not usually very close to the periphery of the section ( Figure 3A) . At higher magnification, these clusters of cells had the characteristic appearance of neuroepithelial bodies (NEBs) ( Figure 3C ) as described in the mouse (12J3). The stained cells were in contact with the basement membrane and were elongated along the basal-luminal axis, but were often separated from the lumen of the airway by unstained cells. The staining tended to be strongest at the basal pole of the cells, where the neurosecretory granules are concentrated ( 5 J3).
In contrast, the anti-CC10 antibody stained most but not all of the cells within the epithelium of the large airways and in restricted regions of the small airways at E18 ( Figure 3B ). The latter presumably represent the most proximal small conducting airways. In fortuitous sections, these small stained airways could be seen to branch directly from large airways, and the regions containing stained cells ended quite abruptly at their distal extremities (Figure 3B ). Unstained cells occurred singly or in small groups or clusters among the anti-CC10-stained cells. By comparison of adjacent sections reacted with anti-CGRP or anti-CC10, we observed that the NEBs usually lay in the epithelium of anti-CC10-positive airways but that the positions of the CGRP-positive NEBs appeared to correspond to gaps in the anti-CC10 staining (compare arrows in Figures  3A and 3B) . A single NEB viewed at high magnification in adjacent sections clearly shows the relationship between the two staining patterns ( Figures 3C and 3D ). The anti-CGRP positive cells lie at the core of the NEB structure, whereas the surrounding cells are negative. In the anti-CC10 stained section, the cells at the core of the NEB show little or no staining, whereas many of the surrounding cells are intensely stained. These staining patterns are consistent with the established cell type-specificity of CGRP and CClO and the known structure of NEBs, in which the central cluster of PNE cells is surrounded by Clara cells (12J3). Figures 4A-4C show a comparison of the immunostaining patterns of anti-CGRP, anti-CC10, and anti-SP-A in a transversely sectioned large airway (left) and the surrounding parenchyma (right) in adjacent sections of E18 lung. Staining in the anti-CGRP-reacted section reveals the position of a large NEB in the large airway epithelium (large arrow) and also a very small NEB in a nearby small airway (small arrow). The small NEB may be located in the epithelium of a proximal small airway. A few anti-CC10-positive cells were found near this location in the adjacent section (excluded when photo was cropped for Figure 4B) . Comparison of the large NEB in the two adjacent sections ( Figures 4B and 4C, open arrows) shows that the core of tall narrow neuroendocrine cells in the large NEB is not stained by either the anti-CC10 or the anti-SP-A antibodies, whereas both of these antibodies show staining in the cap of presumptive Clara cells that covers the luminal surface of the NEB.
The apparent co-expression of CClO and SP-A in the presumptive Clara cell population is seen in the epithelium of all the large airways ( Figures 4B and 4C , e) and extends into the epithelium of the proximal small airways (not shown). Staining of cells in the large airway epithelium with anti-SP-A first appeared at EIS, whereas staining of these cells with the anti-CC10 antibody was apparent 2 days earlier. Other differences between the staining patterns of anti-CC10 and anti-SP-A could be seen in these sections. Anti-CC10 did not stain the lung parenchyma, whereas the anti-SP-A antibody stained many scattered cells associated with the small airways throughout the parenchyma of the lung. Most of these cells were weakly stained, and their identities are uncertain. Occasional anti-SP-A-positive cells, tentatively identified as differentiating Type I1 alveolar cells, were seen in the small airways near the periphery of the section. Their identification is based on their size, intensity of staining, and position at the corners of small air spaces ( Figure  4D, small arrows) . Staining of noncellular material in airway lumens was commonly seen in both anti-CC10-and anti-SP-A-reacted sections, but the patterns differed for the two antibodies. Anti-CC10 stained large masses of material primarily in the lumens of the large airways ( Figure 4B, I ), whereas anti-SP-A stained small, dense clumps of material primarily in the lumens of the small distal airways ( Figure 4C, small arrows) . This material probably represents secreted CClO or SP-A protein. Staining of extracellular material with anti-CC10 was a very consistent observation, whereas the amount of anti-SP-A-positive extracellular material was highly variable from specimen to specimen and appeared to be inversely correlated with the amount of cellular staining in the tissue. This variation might reflect differences in the exact developmental age of the specimens or possibly unidentified differences in the way the tissue was handled during the interval between death of the animal and tissue fixation. Similar sections treated with no primary antibody or with anti-CGRP or anti-CC10 antisera preabsorbed with antigen showed no staining (data not shown).
Organ Culture Studies
We wondered whether the two developmental phases identified in vivo would also be exhibited in our serumless organ culture system. Although the architecture of the lung is distorted in these explants relative to what develops in vivo, substantial growth, airway branching, and cellular differentiation do occur in this model system. An earlier study using lung buds dissected at E12 found that the rate of development in culture is approximately half the rate of development in vivo for the first 9 days in culture (35). For the present study, lungs were removed from embryos at E l l and were grown in culture for either 4 days (E11+4) or 11-12 days ( E l l + Il-Ell+ 12). then fixed, sectioned, and stained immunohistochemically with the three antisera. The results are shown in Figure 5 .
The El 1 + 4 culture timepoint appeared to correspond to the earlier phase of in vivo development. Figures 5A-5C show adjacent sections reacted with anti-CGRP, anti-CC10, and anti-SP-A antisera. The three staining patterns are essentially the same, with continuous staining in some regions of the epithelium (small arrows) and no staining in other regions (open arrows). Although there is not a clear morphological distinction between large airway and small airway epithelium in the lung explants, the existence of both stained and unstained regions of epithelium suggests that both types of epithelium are present. In addition, the regions of stained epithelium tend to lie towards the periphery of the lobes of the cultured lung (compare Figure lF , in which the edge of the lobe is at the upper right, with Figures 5A-5C , in which the edge of the lobe is at the upper left). As is the case in vivo, the coincidence of the staining patterns seen with all three antibodies in the cultured lungs suggests that there is co-expression of all three marker proteins within the same cells.
The E l l + 11-El 1 + 12 timepoint appeared to correspond to the later phase of development identified in vivo. All three marker proteins appeared to be expressed in these older cultured lungs, and the staining patterns obtained had become distinct. Sections reacted with anti-CGRP antiserum contained scattered stained clusters of epithelial cells very reminiscent of the stained NEBS seen in E16-El8 in vivo tissue ( Figure 5D, arrows) . The pattern of anti-CC10 immunostaining in the cultured lung ( Figure 5E ) included extensive regions containing a high frequency of intensely stained cells, with unstained cells interspersed singly or in groups (large arrow). Other extended regions of the epithelium contained no stained cells (small arrows). There was often staining of extracellular material within the lumens of the airways. When it was possible to obtain adjacent sections stained with anti-SP-A ( Figure 5F ), there appeared to be both overlapping and nonoverlapping areas of epithelial staining with the two antisera. Epithelium containing anti-CC10-positive cells, or cells reactive to both antibodies, presumably corresponds to large airway epithelium (Figures 5E and SF, large arrows) and the stained cells are presumptive Clara cells. The fact that it appears that not all of the anti-CC10-positive cells also stained with anti-SP-A may indicate that the cultured lung was not quite uniform with respect to developmental age. Epithelium that contains only anti-SP-A-positive cells presumably corresponds to distal small airway epithelium (small arrows). In general, regions that stained only with anti-CC10 or with both antibodies lay closer to the center of the lung and regions that stained only with anti-SP-A lay at the periphery (Figures SE and 5F the edge of the lung is at the upper right). Even in the epithelial regions that showed the most anti-SP-A staining the staining was discontinuous, with not all of the cells being stained, a feature common to the later but not the earlier developmental stage in vivo. Although it is difficult to say from these results whether the anti-SP-A-stained cells are differentiating Type I1 cells, an earlier study of the organ culture system demonstrated differentiation of Type I1 cells in this system at an equivalent culture time based on ultrastructural demonstration of lamellar body formation as well as SP-A immunofluorescence (35).
Discussion
Our immunohistochemical study has revealed two phases in the development of mouse lung epithelium with respect to immunohistochemical staining patterns using antisera directed against CGRP, CClO, and SP-A in the interval from E13 to E18. The later phase, beginning at E16, is characterized by the emergence of patterns of immunopositive cells that match the known distribution of these marker proteins in differentiated PNE cells, Clara cells, and Type I1 cells in rodents. In contrast, the earlier developmental phase, extending from E13 through E15, is characterized by CGRP, CC10, and SP-A immunostaining in essentially all cells in the epithelium of the smaller, more distal airways. The staining patterns seen during the earlier phase are almost identical for all three marker proteins in adjacent sections.
The specificity of the hmunostaining during the later developmental phase is strongly supported by the preabsorption controls for anti-CGRP and anti-CC10 and by the staining patterns themselves, which are clearly distinct for all three proteins and which conform to patterns that could be predicted from published studies. For the earlier phase, in which all three antisera give the same pattern, the preabsorption controls for anti-CGRP and anti-CC10 demonstrate that the staining with these two antisera is not due to the presence of contaminating antibodies that do not react with CGRP or CC10, respectively. We cannot, however, rule out the possibility that one or more generally distributed epithelial antigens might share an epitope with CGRP, CClO, and/or SP-A, giving the observed staining patterns. The existence of a single epitope shared by all three marker proteins is highly unlikely because the three proteins share neither function nor primary structure (1, 20, 32) . More complex scenarios involving multiple co-expressed epitopes are similarly improbable. We therefore conclude that the most likely explanation for our results is that the staining patterns observed during both the earlier and the later phases of lung development do in fact reflect the true distribution of CGRP, CC10, and SP-A.
A related issue is whether the sites of positive immunostaining represent sites of synthesis of the targeted proteins. Because CGRP, CC10, and SP-A are all secreted products in the mature lung, it is possible that some of the epithelial cells stained with each antiserum at E13-El5 are synthetic sources and that others are stained as a result of uptake of secreted material. However, it does not seem likely that secretion and uptake are involved, because we have not observed any differentially stained subsets of cells that might be the source of the hypothetical secreted gene produces, nor have we observed extracellular staining that might suggest that secretion is occurring during the earlier developmental phase. In situ hybridization studies and electron microscopy will be needed to address these concerns. We conclude, with the above caveats, that CGRP, CC10, and SP-A are expressed in most or all cells of the distal airway epithelium at E13-EI5 and only later become restricted to their respective cell lineages. Because the staining patterns for CGRP, CC10 and SP-A are so nearly identical in adjacent sections of lungs from E13 through El>, we further conclude that coexpression of these proteins must occur in most if not all of the epithelial cells of the small distal airways throughout this period.
The two developmental phases of expression of CGRP, CClO, and SP-A observed in vivo are recapitulated in the serumless organ culture system. The later timepoint examined (11-12 days in culture) shows differentiation of PNE cells and Clara cells, whereas the early timepoint (4 days in culture) exhibits staining patterns that bear a marked resemblance to the patterns observed at E14 in vivo. Since the cultured organs were removed from the embryos at Ell, we conclude that all the information necessary to generate the two phases of gene expression seen in vivo must already be present within the lung anlage by 11 days' gestation, when only the trachea and primary bronchi are present.
Expression of surfactant protein genes before the differentiation of Type I1 cells has been observed by several groups in rodents and humans (18, 19, 30, 42, 45, 47) . As early as 1979, Ten HaveOpbroek (42) reported SP-A immunofluorescence in the distal lung epithelium at E14.2 in the mouse in a pattern very reminiscent of what we have observed at E14 (and earlier) for SP-A, CGRP, and CC10. More recently, interest has focused on expression of SP-C as the only surfactant protein demonstrated to be a specific marker for mature Type I1 cells (16, 27, 30) . Wert and co-workers (47) found that mRNA encoding SP-C was expressed in the epithelium of the distal airways from E l l through E16. Again, the pattern of expression revealed by in situ hybridization was virtually identical between E13 and E15 to what we have observed for CGRP, CC10, and SP-A, strongly suggesting that all four of these genes are expressed in the same precursor cell population at this stage of development. These researchers did not detect mRNA encoding CClO until E16, whereas we detect anti-CC10 immunostaining from E13 onwards. This apparent discrepancy may be due to the different methods used (in situ hybridization vs immunohistochemistry) to detect the different target molecules. That is, the mRNA might be rare and turn over rapidly, whereas the protein might accumulate to a detectable level. Ten Have-Opbroek interpreted the early expression of SP-A to mean that all of the cells in the epithelium of the distal airways at E14 were early Type I1 cells (40.42) . Early expression of SP-C mRNA has been interpreted as an indication that the SP-C-expressing cells are the specific progenitors of the distal respiratory epithelium (47) or that they might be committed to a Type I1 cell phenotype (45). Our results with CGRP, CC10, and SP-A suggest that there may be a need to reevaluate these interpretations, because CGRP expression is not associated with mature Type 11 cells and because both CClO and CGRP are ultimately localized to cells of the conducting airway epithelium, and SP-A is found in cells in both respiratory and conducting airways in the mature lung. Expression of all of these gene products in a progenitor cell population may reflect some aspect of the underlying mechanism of developmental gene regulation rather than early commitment to specific lineages.
We are not aware of other published reports of co-expression in lung epithelial progenitor cells of protein markers for such diverse lineages as PNE cells, Clara cells, and Type I1 cells. Coexpression of Type I and Type I1 cell-specific markers has been reported in lung epithelial cells of the rat at E16 (49). This finding was interpreted as a reflection of the close lineage relationship that is known to exist specifically between Type I and Type I1 cells. In the light of our results in the mouse, it is possible that these cells might also express markers of non-Type IlType I1 cell lineages at this stage of gestation.
Apparent early co-expression of CC10 and SP-A might be viewed as evidence for a close lineage relationship between Clara cells and Type I1 cells, particularly since both of these mature cell types have been reported to express both of these genes. It should be noted, however, that the data presented do not give evidence of coordinate regulation of CClO and SP-A gene expression. Expression of CClO in the distal airway epithelium appears to be extinguished at EI6, about the same time that epithelial cells in the large airways begin to express this protein, and expression of CClO in the proximal small airways follows at about E18. In contrast, SP-A apparently continues to be expressed in a subpopulation of distal epithelial cells from E16 to E18 and does not appear in the epithelium of the large airways and proximal small airways until the end of this period. These patterns of gene expression suggest that the expression of SP-A in both Type I1 cells and Clara cells represents phenotypic convergence relating to some function common to both cell types.
The phenomenon of co-expression of ddferentiated cell markers in lung epithelial progenitor cells clearly requires further study. The findings presented here have a bearing on the underlying mechanism of lung epithelial cell differentiation as well as on the interpretation of cell lineage studies based on expression of specific marker genes in mice and possibly in other species as well.
Literature Cited
